We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$19.1B
AUM Growth
-$71.6M
Cap. Flow
+$375M
Cap. Flow %
1.97%
Top 10 Hldgs %
20.96%
Holding
1,713
New
9
Increased
554
Reduced
98
Closed
38

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$83.2M
2
DQ
Daqo New Energy
DQ
+$42.7M
3
DAR icon
Darling Ingredients
DAR
+$33M
4
TER icon
Teradyne
TER
+$25.8M
5
IQV icon
IQVIA
IQV
+$25.1M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$49.3M
2
ALB icon
Albemarle
ALB
+$38.8M
3
FSLR icon
First Solar
FSLR
+$27.7M
4
NUAN
Nuance Communications, Inc.
NUAN
+$25.1M
5
JCI icon
Johnson Controls International
JCI
+$19.2M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Healthcare 17.68%
3 Consumer Discretionary 14.03%
4 Financials 13.08%
5 Industrials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVA icon
1551
Innoviva
INVA
$1.51B
$345K ﹤0.01%
20,676
– –
FRG
1552
DELISTED
Franchise Group, Inc.
FRG
$343K ﹤0.01%
9,700
– –
ATRA icon
1553
Atara Biotherapeutics
ATRA
$77M
$342K ﹤0.01%
764
– –
SPHR icon
1554
Sphere Entertainment
SPHR
$6.27B
$342K ﹤0.01%
4,700
+1,500
+47% +$112K
BGS icon
1555
B&G Foods
BGS
$297M
$340K ﹤0.01%
11,388
– –
INFN
1556
DELISTED
Infinera Corporation Common Stock
INFN
$338K ﹤0.01%
40,606
– –
EIG icon
1557
Employers Holdings
EIG
$871M
$337K ﹤0.01%
8,537
– –
STBA icon
1558
S&T Bancorp
STBA
$1.82B
$336K ﹤0.01%
11,416
– –
KLRS
1559
Kalaris Therapeutics
KLRS
$93.8M
$336K ﹤0.01%
583
– –
SLQT icon
1560
SelectQuote
SLQT
$128M
$335K ﹤0.01%
25,900
– –
CSGS
1561
DELISTED
CSG Systems International
CSGS
$334K ﹤0.01%
6,930
– –
ZYME icon
1562
Zymeworks
ZYME
$1.82B
$334K ﹤0.01%
11,500
– –
RVMD icon
1563
Revolution Medicines
RVMD
$43.8B
$333K ﹤0.01%
12,100
– –
PRO
1564
DELISTED
PROS Holdings
PRO
$330K ﹤0.01%
9,300
– –
PGTI
1565
DELISTED
PGT, Inc.
PGTI
$330K ﹤0.01%
17,300
+3,800
+28% +$81.1K
GCP
1566
DELISTED
GCP Applied Technologies Inc.
GCP
$330K ﹤0.01%
15,060
– –
ALLO icon
1567
Allogene Therapeutics
ALLO
$711M
$326K ﹤0.01%
12,700
– –
RTL
1568
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$324K ﹤0.01%
40,352
+9,300
+30% +$78.6K
NTUS
1569
DELISTED
Natus Medical Inc
NTUS
$324K ﹤0.01%
12,930
– –
GBT
1570
DELISTED
Global Blood Therapeutics, Inc.
GBT
$322K ﹤0.01%
12,644
– –
TBI
1571
Trueblue
TBI
$303M
$320K ﹤0.01%
11,816
– –
BANC icon
1572
Banc of California
BANC
$3.14B
$318K ﹤0.01%
17,195
– –
SGMO
1573
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$318K ﹤0.01%
35,246
– –
VNDA icon
1574
Vanda Pharmaceuticals
VNDA
$308M
$317K ﹤0.01%
18,500
+5,700
+45% +$99.8K
IRTC icon
1575
iRhythm Holdings
IRTC
$4.12B
$316K ﹤0.01%
5,400
– –
61 62
63
64 65

Similar funds

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Handelsbanken Fonder's Q3 2021 Portfolio in Review

As of Q3 2021, Handelsbanken Fonder held 1,713 positions worth $19.1B, down 0.37% from $19.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. Handelsbanken Fonder opened 9 new positions and exited 38, leaving the 1,713-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q3 2021 buy was Volta Inc.: 1,671,677 shares worth $14.5M.
  • Handelsbanken Fonder added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $83.2M increase.
  • Handelsbanken Fonder's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.3M.
  • Handelsbanken Fonder fully exited Johnson Controls International in Q3 2021, selling an estimated $19.2M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $19.1B portfolio in Q3 2021.
  • Handelsbanken Fonder opened 9 new positions and closed 38 in Q3 2021.
  • Handelsbanken Fonder's portfolio value fell 0.37% quarter-over-quarter to $19.1B.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.